BioTech Nation Radio with Dr Moira Gunn
On this week’s BioTech Nation, DR. DANIEL KRAFT, the Chair of Medicine at Singularity University. He’s the Founder of Exponential Medicine, the annual fall conference each year in San Diego, which brings together people interested in the frontiers of medicine, and the technology that can drive it.
On Biotech Nation, DR. KEVIN JUDICE, President and CEO of DICE Molecules tells us why every medication can be delivered in pill form. And also DR. THOMAS HALLAM from Leading Biosciences. We’ll hear about the work they are doing to intervene when a person goes into shock.
On Biotech Nation, efforts to treat the rare genetic cardiovascular disorder – HCM. You will recognize it as the leading cause of sudden death in young athletes. Tassos Gianokakos, the CEO of MyoKardia, tells us about the condition, the impact on families and Myokardia’s approach.
On this week’s BioTech Nation, the focus is Alzheimer’s Disease. Dr. Gunn speaks with Kevin Cox, CEO of Imanova about the ability to actually examine the state of the brain on a more routine basis, improving diagnosis and predicting the success or failure of drugs. Then, it’s Dr. Charles Stacey, the President and CEO of Accera. The basis for their Alzheimer’s treatment centers on glucose uptake in the brain.
On this week’s BioTech Nation, Andreas Weigand, former chief scientist at Amazon, and author of “Data for the People.” Then on Tech Nation Health, Dr. Marshall Summar, Director of the Rare Disease Institute and Chief of Genetics and Metabolism at Children’s National Health System in Washington, DC. They talk about treating rare diseases in the very young, and the efforts to support families, local pediatricians and the patients themselves, nationwide and around the world.
On this week’s BioTech Nation, a full hour of Tech Nation Health, reimagining the future of health and healthcare with the emergence of new technologies. DR. DANIEL KRAFT, Chief Correspondent for Tech Nation Health talks about the future of Surgery and Other Interventions. Purdue Professor, DR. PHIL LOW, the Director of Purdue Center for Drug Discovery and Chief Scientific Officer of Endocyte, talks about why it’s hard to surgically remove all the cancerous tissue, and a technology that can change that. And DR. RICHARD KUHN, the Director of the Purdue Institute for Inflammation, Immunology and Infectious Disease. He was the first to discover the structure of the Zika virus, and he compares it to other viruses, like Polio and HIV.
On this week’s BioTech Nation, in the pediatric area, diagnosing some behavioral problems and mental disorders by testing the immune system. Dr. Craig Shimasaki, the CEO of Moleculera Labs, explains their test and the science behind it.
On this week’s BioTech Nation, correcting the underrepresentation of Latinos in testing pharmaceuticals and directly addressing the Zika virus in humans. Dr. Kosmas Kretsos, the Executive Director of the Puerto Rico Consortium for Clinical Investigation (PRCCI) describes the efforts underway in Puerto Rico.
On this week’s BioTech Nation, a new approach to achieving health with a compromised immune system. Dr. DAVID JOHNSON is the Founder, President & CEO of GigaGen. And critically-ill newborns get the genetic information they need … and fast. GAVIN STONE is the Vice President for Marketing at EdicoGenome in San Diego.
On this week’s Bio Tech Nation, neuroscientist Daniel Levitin talks about how we can tell the difference between a simple lie and a weaponized lie. His book is “Weaponized Lies: How to Think Critically in the Post-Truth Era.” Then on Tech Nation Health, chief correspondent Dr. Daniel Kraft tells us about The Internet of Medical Things. And what it can do for us.
